Structure-Function Correlation in Macular Degeneration
Principal Investigator
Hendrik Scholl, MD
Institute of Molecular and Clinical Ophthalmology Basel (Switzerland)
Basel, Switzerland
About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2010 - December 31, 2012
Grant ID
M2010042
Goals
This study may be the first methodology for an exact point-by-point structure-function correlation of pathology within the central retina. This diagnostic technology is extremely promising to establish new surrogate endpoints for clinical trials and for monitoring treatment effects on visual function with highest accuracy.
Grantee institution at the time of this grant: Wilmer Eye Institute
Summary
The human central retina, the macula, is both the anatomical structure responsible for fine detail vision and subject to disease-causing irreversible blindness. Remarkable progress has been made in high-resolution imaging of the macula using new technologies such as optical coherence tomography (OCT). However, the impact of retinal pathology detected by such high-resolution imaging on visual performance remains mostly uncertain.
To investigate the functional consequences of pathology detected by high-resolution retinal imaging, data of visual function will be superimposed onto all topographic and tomographic images of the retina.
Selected morphological features will be validated, and their applicability will be investigated as surrogate markers for future clinical trials in macular diseases.
This approach of an exact point-by-point structure-function correlation of pathology within the central retina may offer unique insights in macular disease mechanisms and may offer a perfect monitoring tool for any type of therapeutic intervention in macular degeneration.
Grants
Related Grants
Macular Degeneration Research
Exploring How NRF2 Protein Reduces RPE Cell Damage by Cigarette Smoke
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Krishna Singh, PhD
Exploring How NRF2 Protein Reduces RPE Cell Damage by Cigarette Smoke
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Krishna Singh, PhD
Macular Degeneration Research
The Development of a Transplant-Independent Therapy for RPE Dysfunction
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Shintaro Shirahama, MD, PhD
The Development of a Transplant-Independent Therapy for RPE Dysfunction
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Shintaro Shirahama, MD, PhD
Macular Degeneration Research
Regeneration of Cone Photoreceptors in the Human Retina
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Juliette Wohlschlegel, PhD
Regeneration of Cone Photoreceptors in the Human Retina
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Juliette Wohlschlegel, PhD